{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:50:34Z","timestamp":1761540634559},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,7,1]],"date-time":"1994-07-01T00:00:00Z","timestamp":773020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1994,7]]},"DOI":"10.1007\/bf01757345","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T17:40:03Z","timestamp":1118857203000},"page":"33-40","source":"Crossref","is-referenced-by-count":42,"title":["Hematologic aspects of end-stage renal failure"],"prefix":"10.1007","volume":"69","author":[{"given":"P.","family":"Zach\u00e9e","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vermylen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Boogaerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01757345_CR1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0272-6386(12)80725-6","volume":"21","author":"MA Arnaout","year":"1993","unstructured":"Arnaout MA (1993) Cell adhesion molecules in inflammation and thrombosis: status and prospects. Am J Kidney Dis 21:72\u201376","journal-title":"Am J Kidney Dis"},{"key":"BF01757345_CR2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/41.3.8429197","volume":"41","author":"S Bachmann","year":"1993","unstructured":"Bachmann S, Lehir M, Eckardt KU (1993) Colocalization of erythropoietin messenger-RNA and ecto-5\u2032-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 41:335\u2013341","journal-title":"J Histochem Cytochem"},{"key":"BF01757345_CR3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000183512","volume":"40","author":"N Bazilinski","year":"1985","unstructured":"Bazilinski N, Shaykh M, Dunea G et al (1985) Inhibition of platelet function by uremic middle molecules. Nephron 40:423\u2013428","journal-title":"Nephron"},{"key":"BF01757345_CR4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2141.1986.tb02910.x","volume":"62","author":"A Bloom","year":"1986","unstructured":"Bloom A, Greaves M, Preston FE et al (1986) Evidence against a platelet cyclooxigenase defect in uraemic subjects on chronic haemodialysis. Br J Haematol 62:143\u2013149","journal-title":"Br J Haematol"},{"key":"BF01757345_CR5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ndt\/5.7.504","volume":"5","author":"JR Boelaert","year":"1990","unstructured":"Boelaert JR, Cantinieaux BF, Hariga CF, Fondu PG (1990) Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients. Nephrol Dial Transplant 5:504\u2013507","journal-title":"Nephrol Dial Transplant"},{"key":"BF01757345_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0889-8588(18)30509-4","volume":"1","author":"AC Carvalho","year":"1990","unstructured":"Carvalho AC (1990) Acquired platelet dysfunction in patients with uremia. Hematol Oncol Clin North Am 1:129\u2013143","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF01757345_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000183270","volume":"38","author":"DA Casciato","year":"1984","unstructured":"Casciato DA, McAdam LP, Kopple JD et al (1984) Immunologic abnormalities in hemodialysis patients: improvement after pyridoxine therapy. Nephron 38:9\u201316","journal-title":"Nephron"},{"key":"BF01757345_CR8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(66)91802-2","volume":"2","author":"PA Castaldi","year":"1966","unstructured":"Castaldi PA, Rozenberg MC, Stewart JH (1966) The bleeding disorders of uraemia. Lancet 2:66","journal-title":"Lancet"},{"key":"BF01757345_CR9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/blood.V68.2.337.337","volume":"68","author":"R Castillo","year":"1986","unstructured":"Castillo R, Lozano T, Escolar G, Revert L, Lopez J, Ordinas A (1986) Defective platelet adhesion on vessel subendothelium in uremic patients. Blood 68:337\u2013341","journal-title":"Blood"},{"key":"BF01757345_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0065-3101(24)00182-8","volume":"35","author":"M Chandra","year":"1988","unstructured":"Chandra M, McVivar M, Clemons GK (1988) Pathogenesis of the anemia of chronic renal failure: the role of erythropoietin. Adv Pediatr 35:361\u2013389","journal-title":"Adv Pediatr"},{"key":"BF01757345_CR11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0272-6386(12)81017-1","volume":"16","author":"JS Cheigh","year":"1990","unstructured":"Cheigh JS, Kim H, Stenzel KM, Tapia L, Sullivan JF, Stubenbord W, Riggio RR, Rubin AL (1990) Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity. Am J Kidney Dis 16:189\u2013195","journal-title":"Am J Kidney Dis"},{"key":"BF01757345_CR12","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ndt\/7.12.1194","volume":"14","author":"SL Chew","year":"1992","unstructured":"Chew SL, Lins RL, Daelemans R, Zachee P, De Clerck LS, Vermylen J (1992) Are antiphospholipid antibodies clinicallly relevant in dialysis patients? Nephrol Dial Transplant 14:1194\u20131198","journal-title":"Nephrol Dial Transplant"},{"key":"BF01757345_CR13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000415481","volume":"62","author":"J Cledes","year":"1988","unstructured":"Cledes J, Guillodo MP, Herv\u00e9 JP, Bourbigot B, Gentric A, Treguer MH, Wehbe B, Le Bihan G (1988) Hemodialysis hypereosinophilia. Contrib Nephrol 62:109\u2013117","journal-title":"Contrib Nephrol"},{"key":"BF01757345_CR14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/ndt\/5.1.45","volume":"5","author":"PC D'Haese","year":"1990","unstructured":"D'Haese PC, Clement JP, Elseviers MM, Lamberts LV, Van de Vyver FL, Visser WJ, De Broe ME (1990) Value of serum aluminium monitoring in dialysis patients: a multicenter study. Nephrol Dial Transplant 5:45\u201353","journal-title":"Nephrol Dial Transplant"},{"key":"BF01757345_CR15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-88-1-28","volume":"88","author":"JF Dobkin","year":"1978","unstructured":"Dobkin JF, Miller MH, Steigbigel NH (1978) Septicemia in patient on chronic hemodialysis. Ann Intern Med 88:28\u201333","journal-title":"Ann Intern Med"},{"key":"BF01757345_CR16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0049-3848(91)90377-9","volume":"62","author":"DT Domoto","year":"1991","unstructured":"Domoto DT, Bauman JE, Joinst JH (1991) Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. Thromb Res 62:737\u2013743","journal-title":"Thromb Res"},{"issue":"Suppl 2","key":"BF01757345_CR17","first-page":"34","volume":"10","author":"TB Dr\u00fceke","year":"1990","unstructured":"Dr\u00fceke TB (1990) Resistance to recombinant human erythropoietin in hemodialysis patients. Am J Nephrol 10 [Suppl 2]:34\u201339","journal-title":"Am J Nephrol"},{"key":"BF01757345_CR18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000166482","volume":"1","author":"G Eknoyan","year":"1981","unstructured":"Eknoyan G, Brown GH (1981) Biochemical abnormalities of platelets in renal failure: evidence for decreased platelet serotonin triphosphatase. Am J Nephrol 1:17\u201323","journal-title":"Am J Nephrol"},{"key":"BF01757345_CR19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000416004","volume":"66","author":"JW Eschbach","year":"1988","unstructured":"Eschbach JW, Adamson JW (1988) Modern aspects of the pathophysiology of renal anemia. Contrib Nephrol 66:63\u201370","journal-title":"Contrib Nephrol"},{"key":"BF01757345_CR20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000418267","volume":"78","author":"JW Eschbach","year":"1990","unstructured":"Eschbach JW, Haley NR, Adamson JW (1990) The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin. Contrib Nephrol 78:24\u201337","journal-title":"Contrib Nephrol"},{"key":"BF01757345_CR21","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood.V76.7.1336.1336","volume":"76","author":"G Escolar","year":"1990","unstructured":"Escolar G, Casa A, Bastidi E (1990) Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb-IIIa. Blood 76:1336\u20131340","journal-title":"Blood"},{"key":"BF01757345_CR22","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJM199105093241907","volume":"324","author":"AJ Erslev","year":"1991","unstructured":"Erslev AJ (1991) Erythropoietin. N Engl J Med 324:1339\u20131344","journal-title":"N Engl J Med"},{"key":"BF01757345_CR23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2141.1985.tb02974.x","volume":"59","author":"F Fernandez","year":"1985","unstructured":"Fernandez F, Goudable C, Sie P, Ton-That H, Durand D, Sue JM, Boneu B (1985) Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Br J Haematol 59:139\u2013148","journal-title":"Br J Haematol"},{"key":"BF01757345_CR24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000184118","volume":"45","author":"U Gafter","year":"1987","unstructured":"Gafter U, Bessler H, Malachi T, Zevin D, Djaldetti M, Levi J (1987) Platelet count and thrombopoietic activity in patients with chronic renal failure. Nephron 45:207\u2013210","journal-title":"Nephron"},{"key":"BF01757345_CR25","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1126\/science.2849206","volume":"242","author":"MA Goldberg","year":"1988","unstructured":"Goldberg MA, Dunning SP, Bunn HF (1988) Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 242:1412\u20131415","journal-title":"Science"},{"key":"BF01757345_CR26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.7326\/0003-4819-93-4-597","volume":"93","author":"SE Goldblum","year":"1980","unstructured":"Goldblum SE, Reed WP (1980) Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 93:597\u2013613","journal-title":"Ann Intern Med"},{"key":"BF01757345_CR27","first-page":"971","volume":"88","author":"WH Greene","year":"1976","unstructured":"Greene WH, Ray C, Mauer SM, Quie PG (1976) The effect of hemodialysis on neutrophil chemotactic responsiveness. J Lab Clin Med 88:971\u2013974","journal-title":"J Lab Clin Med"},{"key":"BF01757345_CR28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000417908","volume":"76","author":"P Gr\u00fctzmacher","year":"1989","unstructured":"Gr\u00fctzmacher P, Ehmer B, Messinger D (1989) Effect of aluminum overload on the bone marrow response to recombinant erythropoietin. Contrib Nephrol 76:315\u2013323","journal-title":"Contrib Nephrol"},{"key":"BF01757345_CR29","first-page":"181","volume":"11","author":"V Gura","year":"1979","unstructured":"Gura V, Creter D, Levi J (1979) Elevated thrombocyte calcium in uremia and its correction by 1\u03b1(OH) vitamin D treatment. Nephron 11:181\u2013189","journal-title":"Nephron"},{"key":"BF01757345_CR30","first-page":"102","volume":"96","author":"J Guzzo","year":"1980","unstructured":"Guzzo J, Niewiarowski S, Musial J, et al (1980) Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure. J Lab Clin Med 96:102\u2013113","journal-title":"J Lab Clin Med"},{"key":"BF01757345_CR31","first-page":"64","volume":"94","author":"H H\u00e4llgren","year":"1979","unstructured":"H\u00e4llgren H, Fjellstr\u00f6m KE, H\u00e4kansson L, Venge P (1979) Kinetic studies of phagocytosis. II. The serum-independent uptake of IgG-coated particles by polymorphonuclear leukocytes from uremic patients on regular dialysis treatment. J Lab Clin Med 94:64\u201368","journal-title":"J Lab Clin Med"},{"key":"BF01757345_CR32","first-page":"91","volume":"2","author":"DE Hammerschmidt","year":"1985","unstructured":"Hammerschmidt DE, Goldberg R, Raij L, Kay NE (1985) Leukocyte abnormalities in renal failure and hemodialysis. Semin Nephrol 2:91\u2013103","journal-title":"Semin Nephrol"},{"key":"BF01757345_CR33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ki.1992.54","volume":"41","author":"J Himmelfarb","year":"1992","unstructured":"Himmelfarb J, Zaoui P, Hakim R (1992) Modulation of granulocyte LAM-1 and MAC-1 during dialysis \u2014 a prospective, randomized controlled tial. Kidney Int 41:388\u2013395","journal-title":"Kidney Int"},{"key":"BF01757345_CR34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000185081","volume":"49","author":"Y Hirabayashi","year":"1988","unstructured":"Hirabayashi Y, Kobayashi T, Nishikawa A, Okazaki H, Aoki T, Takaya J, Kobayashi T (1988) Oxidative metabolism and phagocytosis of polymorphonuclear leukocytes in patients with chronic renal failure. Nephron 49:305\u2013312","journal-title":"Nephron"},{"key":"BF01757345_CR35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0002-9343(70)80025-0","volume":"49","author":"HI Horowitz","year":"1970","unstructured":"Horowitz HI, Stein IM, Cohen BD (1970) Further studies on the platelet-inhibiting effect of guanidino-succinic acid and its role in uremic bleeding. Am J Med 49:336\u2013345","journal-title":"Am J Med"},{"key":"BF01757345_CR36","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ki.1991.296","volume":"40","author":"E H\u00fcbel","year":"1991","unstructured":"H\u00fcbel E, Kiefer T, Weber J, Mettano T, Kuhlmann U (1991) In vivo effect of 1,25-dihydroxyvitamin D3 on phagocyte function in hemodialysis patients. Kidney Int 40:927\u2013933","journal-title":"Kidney Int"},{"key":"BF01757345_CR37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0272-6386(85)80112-8","volume":"V","author":"SJ Jubelirer","year":"1985","unstructured":"Jubelirer SJ (1985) Hemostatic abnormalities in renal disease. Am J Kidney Dis V:219\u2013225","journal-title":"Am J Kidney Dis"},{"key":"BF01757345_CR38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00002480-197700230-00012","volume":"23","author":"WF Keane","year":"1977","unstructured":"Keane WF, Shapiro FL, Raij L (1977) Incidence and type of infections occurring in 445 chronic hemodialysis patients. Trans Am Soc Artif Intern Organs 23:41\u201347","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"BF01757345_CR39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/978-94-009-6768-7_33","volume-title":"Replacment of renal function by dialysis","author":"WF Keane","year":"1983","unstructured":"Keane WF, Raij LR (1983) Host defenses and infectious complications in maintenance hemodialysis patients. In: Drukker W, Parson FM, Maher JF (eds) Replacment of renal function by dialysis, 2nd edn. Martinus Nijhoff, Boston, pp 646\u2013658","edition":"2nd edn"},{"key":"BF01757345_CR40","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/ki.1988.116","volume":"33","author":"PL Kimmel","year":"1988","unstructured":"Kimmel PL, Watkins DW, Teller EB, Khanna R, Dosa S, Phillips TM (1988) Zinc balance in combined zinc deficiency and uremia. Kidney Int 33:1091\u20131099","journal-title":"Kidney Int"},{"key":"BF01757345_CR41","volume-title":"Plasma interleukin-1 levels are raised in end-stage renal disease patients on long-term hemodialysis (Abstract 80A)","author":"KM Koch","year":"1986","unstructured":"Koch KM, Shaldon S, Bingel M, et al (1986) Plasma interleukin-1 levels are raised in end-stage renal disease patients on long-term hemodialysis (Abstract 80A). Am Soc Nephrol, Washington, DC, December"},{"key":"BF01757345_CR42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ki.1984.18","volume":"25","author":"H K\u00f6hler","year":"1984","unstructured":"K\u00f6hler H, Arnold W, Renschin G, Dormeyer HH, Meyer zum B\u00fcschenfelde KH (1984) Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int 25:124\u2013128","journal-title":"Kidney Int"},{"key":"BF01757345_CR43","first-page":"642","volume":"114","author":"M Komarnicki","year":"1987","unstructured":"Komarnicki M, Twardowski T (1987) Platelet glycoprotein concentrations in patients with chronic uraemia. Folia Haematol (Leipz) 114:642\u2013645","journal-title":"Folia Haematol (Leipz)"},{"key":"BF01757345_CR44","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJM198609183151204","volume":"315","author":"M Livio","year":"1986","unstructured":"Livio M, Mannucci PM, Vigamo G, Mingardi G, Lombardi R, Mecca G, Remuzzi G (1986) Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 315:731\u2013735","journal-title":"N Engl J Med"},{"key":"BF01757345_CR45","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(82)90050-2","volume":"2","author":"M Livio","year":"1982","unstructured":"Livio M, Marchesi D, Remuzzi G, Gotti E, Mecca G, de Gaetano G (1982) Uramic bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet 2:1013\u20131015","journal-title":"Lancet"},{"key":"BF01757345_CR46","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(84)90652-4","volume":"2","author":"Y Liu","year":"1984","unstructured":"Liu Y, Kosfeld RE, Marcum SG (1984) Treatment of uraemic bleeding with conjugated oestrogen. Lancet 2:887\u2013889","journal-title":"Lancet"},{"key":"BF01757345_CR47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000185241","volume":"51","author":"L Lucchi","year":"1989","unstructured":"Lucchi L, Cappelli G, Acerbi MA, Spattini A, Lusvarghi E (1989) Oxidative metabolism of polymorphonuclear leukocytes and serum opsonic activity in chronic renal failure. Nephron 51:44\u201350","journal-title":"Nephron"},{"key":"BF01757345_CR48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ki.1987.175","volume":"32","author":"A Luger","year":"1987","unstructured":"Luger A, Kovarik J, Stummvoll H, Urbanska A, Luger TA (1987) Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 32:84\u201388","journal-title":"Kidney Int"},{"key":"BF01757345_CR49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/infdis\/154.3.471","volume":"154","author":"EG Maderazo","year":"1986","unstructured":"Maderazo EG, Woronick CL, Albano SD, Breaux SP, Pock RM (1986) Inappropriate activation, deactivation, and probable autooxidative damage as a mechanism of neutrophil locomotory defect. J Infect Dis 154:471\u2013477","journal-title":"J Infect Dis"},{"key":"BF01757345_CR50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM198301063080102","volume":"308","author":"PM Mannucci","year":"1983","unstructured":"Mannucci PM, Remuzzi G, Pusineri F, et al (1983) Deamino-8D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308:8\u201312","journal-title":"N Engl J Med"},{"key":"BF01757345_CR51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0272-6386(82)80055-3","volume":"1","author":"WD Mattern","year":"1982","unstructured":"Mattern WD, Hak LJ, Lamanna RW, Teasle KM, Laffell MS (1982) Malnutrition, altered immune function, and risk of infection in maintenance hemodialysis patients. Am J Kidney Dis 1:206\u2013218","journal-title":"Am J Kidney Dis"},{"key":"BF01757345_CR52","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/ki.1993.362","volume":"44","author":"PH Maxwell","year":"1993","unstructured":"Maxwell PH, Osmond MK, Pugh CW, Heryet A, Nicholls LG, Tan CC, Doe BG, Ferguson DJP, Johnson MH, Ratcliffe PJ (1993) Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 44:1149\u20131162","journal-title":"Kidney Int"},{"key":"BF01757345_CR53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0140-6736(89)91674-7","volume":"1","author":"SC Meuer","year":"1989","unstructured":"Meuer SC, Hauer M, Kurz P, Meyer zum B\u00fcschenfelde KH, K\u00f6hler H (1989) Low-dose interleukin-2 induces systemic immune responses against HbsAg in immunodeficient nonresponders to hepatitis B vaccination. Lancet 1:15\u201318","journal-title":"Lancet"},{"key":"BF01757345_CR54","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000181858","volume":"25","author":"D Modai","year":"1980","unstructured":"Modai D, Sagi DB, Maor J (1980) Effect of levamisole on skin reactions to DNCB in chronically dialyzed patients. Nephron 25:280\u2013282","journal-title":"Nephron"},{"key":"BF01757345_CR55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000169452","volume":"5","author":"JO Pedersen","year":"1987","unstructured":"Pedersen JO, Knudson F, Nielsen AH, Grummet N (1987) The ability of uremic serum to induce neutrophil chemotaxis in relation to hemodialysis. Blood Purif 5:24\u201328","journal-title":"Blood Purif"},{"key":"BF01757345_CR56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0272-6386(89)80187-8","volume":"14","author":"FK Port","year":"1989","unstructured":"Port FK, Ragheb NE, Schwartz AG, Hawthorne VM (1989) Neoplasms in dialysis patients: a population-based study. Am J Kidney Dis 14:119\u2013123","journal-title":"Am J Kidney Dis"},{"key":"BF01757345_CR57","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0002-9343(70)80026-2","volume":"49","author":"SF Rabiner","year":"1970","unstructured":"Rabiner SF, Molinas F (1970) The role of phenol and phenolic acids on the thrombocytopathy and defective platelet aggregation of patients with renal failure. Am J Med 49:346\u2013351","journal-title":"Am J Med"},{"key":"BF01757345_CR58","first-page":"913","volume":"1","author":"AK Rao","year":"1986","unstructured":"Rao AK (1986) Uraemic platelets. Lancet 1:913\u2013914","journal-title":"Lancet"},{"key":"BF01757345_CR59","first-page":"132","volume":"1","author":"G Remuzzi","year":"1981","unstructured":"Remuzzi G, Benigni A, Dodessini P (1981) Parathyroid hormone inhibits human platelet function. Lancet 1:132\u2013223","journal-title":"Lancet"},{"key":"BF01757345_CR60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000181474","volume":"22","author":"G Remuzzi","year":"1978","unstructured":"Remuzzi G, Livio M, Marchiaro G, Mecca G, de Gaetano G (1978) Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron 22:347\u2013353","journal-title":"Nephron"},{"key":"BF01757345_CR61","first-page":"109","volume":"13","author":"S Ringoir","year":"1980","unstructured":"Ringoir S, Van Landschoot N, De Smet R (1980) Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate. Clin Nephrol 13:109\u2013112","journal-title":"Clin Nephrol"},{"key":"BF01757345_CR62","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ki.1981.26","volume":"19","author":"EE Ritchey","year":"1981","unstructured":"Ritchey EE, Wallin JD, Shah SV (1981) Chemiluminescence and superoxide anion production by leukocytes from chronic hemodialysis patients. Kidney Int 19:349\u2013358","journal-title":"Kidney Int"},{"key":"BF01757345_CR63","first-page":"1203","volume":"2","author":"LB Rodger","year":"1992","unstructured":"Rodger LB (1992) Acquired platelet function defects in perplexing thrombotic and hemorrhagic disorders. Hematol Oncol Clin North Am 2:1203\u20131228","journal-title":"Hematol Oncol Clin North Am"},{"key":"BF01757345_CR64","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJM199003153221102","volume":"11","author":"P Ruiz","year":"1990","unstructured":"Ruiz P, Gomez F, Schreiber AD (1990) Impaired function of macrophage Fc, receptors in end-stage renal disease. New Engl J Med 11:717\u2013722","journal-title":"New Engl J Med"},{"key":"BF01757345_CR65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ki.1991.189","volume":"40","author":"JJ Sennesael","year":"1991","unstructured":"Sennesael JJ, Van Der Niepen P, Verbeelen DL (1991) Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients. Kidney Int 40:121\u2013128","journal-title":"Kidney Int"},{"key":"BF01757345_CR66","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2141.1985.tb02872.x","volume":"61","author":"DP Singal","year":"1985","unstructured":"Singal DP, Ludwin D, Blajchman MA (1985) Blood transfusion and renal transplantation. Br J Haematol 61:595\u2013602","journal-title":"Br J Haematol"},{"key":"BF01757345_CR67","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000167466","volume":"7","author":"H Sinzinger","year":"1978","unstructured":"Sinzinger H, Leither C (1978) Eicosanoids of platelets and vascular wall in chronic renal insufficiency. Am J Nephrol 7:212\u2013220","journal-title":"Am J Nephrol"},{"key":"BF01757345_CR68","first-page":"402","volume":"92","author":"P Siriwatratananonta","year":"1978","unstructured":"Siriwatratananonta P, Sinsakul V, Stern K, Slavin RG (1978) Defective chemotaxis in uremia. J Lab Clin Med 92:402\u2013407","journal-title":"J Lab Clin Med"},{"key":"BF01757345_CR69","first-page":"282","volume":"90","author":"JS Solomkin","year":"1981","unstructured":"Solomkin JS, Jenkins MK, Nelson RD, Chenoweth D, Simmons RL (1981) Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation. Surgery 90:282\u2013286","journal-title":"Surgery"},{"key":"BF01757345_CR70","first-page":"409","volume":"36","author":"JH Stewart","year":"1967","unstructured":"Stewart JH, Castaldi PA (1967) Uraemic bleeding: a reversible platelet defect corrected by dialysis. Q J Med 36:409\u2013423","journal-title":"Q J Med"},{"key":"BF01757345_CR71","first-page":"41","volume-title":"Clinical approach to infection in the compromised host","author":"JWM Meer Van der","year":"1988","unstructured":"Van der Meer JWM (1988) Defects in host-defense mechanisms. In: Rubin RH, Young LS (eds) Clinical approach to infection in the compromised host, 2nd edn. Plenum Medical, New York, pp 41\u201373","edition":"2nd edn"},{"key":"BF01757345_CR72","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0038-1646538","volume":"61","author":"C Geet Van","year":"1989","unstructured":"Van Geet C, Hauglustaine D, Verresen L, Vanrusselt M, Vermylen J (1989) Haemostatic effects of recombinant human erythropoietin in chronic haemodialysis patients. Thromb Haemost 61:117\u2013121","journal-title":"Thromb Haemost"},{"key":"BF01757345_CR73","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ki.1991.40","volume":"39","author":"R Vanholder","year":"1991","unstructured":"Vanholder R, Ringoir S, Dhondt A, Hakim R (1991) Phagocytosis in uremic and hemodialysis patients: a prospective and cross-sectional study. Kidney Int 39:320\u2013327","journal-title":"Kidney Int"},{"key":"BF01757345_CR74","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2362.1982.tb00683.x","volume":"12","author":"J Vlacoyannis","year":"1982","unstructured":"Vlacoyannis J, Schoeppe W (1982) Adenylate cyclase activity and cAMP content of human platelets in uraemia. Eur J Clin Invest 12:379\u2013439","journal-title":"Eur J Clin Invest"},{"key":"BF01757345_CR75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000207230","volume":"64","author":"EN Wardle","year":"1980","unstructured":"Wardle EN, Williams R (1980) Polymorph leukocyte function in uremia and jaundice. Acta Haematol 64:157\u2013164","journal-title":"Acta Haematol"},{"key":"BF01757345_CR76","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1182\/blood.V73.1.172.172","volume":"73","author":"AJ Ware","year":"1988","unstructured":"Ware AJ, Clark BA, Smith M, Salzman EW (1988) Abnormalities of cytoplasmic Ca++ in platelets from patients with uremia. Blood 73:172\u2013176","journal-title":"Blood"},{"key":"BF01757345_CR77","doi-asserted-by":"crossref","first-page":"678","DOI":"10.7326\/0003-4819-107-5-678","volume":"107","author":"DW Windus","year":"1987","unstructured":"Windus DW, Stokes TJ, Julian BA, Fenves AZ (1987) FatalRhizopus infections in hemodialysis patients recieving deferoxamine. Ann Intern Med 107:678\u2013680","journal-title":"Ann Intern Med"},{"key":"BF01757345_CR78","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(86)92192-6","volume":"2","author":"CG Winearls","year":"1986","unstructured":"Winearls CG, Pippard MJ, Downing MR, Oliver DO, Reid C, Cotes PM (1986) Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic hemodialysis. Lancet 2:1175\u20131178","journal-title":"Lancet"},{"key":"BF01757345_CR79","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/BF01735316","volume":"64","author":"M Winkelmann","year":"1986","unstructured":"Winkelmann M, Dorr U, Pfitzer P et al (1986) Is lower ploidy megakaryocytes another reason for uremic thrombocytopathy? Klin Wochenschr 64:540\u2013544","journal-title":"Klin Wochenschr"},{"key":"BF01757345_CR80","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(83)91954-2","volume":"1","author":"M Winter","year":"1983","unstructured":"Winter M, Seghatchian MJ, Cameron JS (1983) An abnormal factor VIII molecule in uremia? Lancet 1:1112","journal-title":"Lancet"},{"key":"BF01757345_CR81","first-page":"439","volume":"8","author":"P Zach\u00e9e","year":"1988","unstructured":"Zach\u00e9e P, Emonds MP, Goossens W, Daelemans R, Lins RL, Boogaerts MA (1988) Erythrocyte deformability and oxidative sensitivity in hemodialysis patients. Clin Hemorheol 8:439\u2013443","journal-title":"Clin Hemorheol"},{"key":"BF01757345_CR82","first-page":"104","volume":"4","author":"P Zach\u00e9e","year":"1988","unstructured":"Zach\u00e9e P, Emonds MP, Lins RL, Boogaerts MA (1988) Red blood cells, the scavengers for toxic free radicals during haemodialysis. Nephrol Dial Transplant 4:104\u2013105","journal-title":"Nephrol Dial Transplant"},{"key":"BF01757345_CR83","unstructured":"Zach\u00e9e P, Normohamed MT, Daelemans R, Stevens P, Cate JW, Hoek JA, Lins RL (1991) Efficacy and safety of low-molecular-weight heparin versus unfractionated heparin in 100 chronic haemodialysis patients. (Abstract no 5) General Meeting of the Belgian Hematological Society"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01757345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01757345\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01757345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T21:31:42Z","timestamp":1706304702000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01757345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,7]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,7]]}},"alternative-id":["BF01757345"],"URL":"https:\/\/doi.org\/10.1007\/bf01757345","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,7]]}}}